|
ESPR Esperion Therapeutics Inc 1434868 |
| Balance Sheet |
|
Current Assets
|
337,998,000 |
|
Assets
|
343,821,000 |
|
Current Liabilities
|
246,233,000 |
|
Liabilities
|
732,543,000 |
|
Equity
|
-388,722,000 |
|
Shares Out
|
196,225,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-23,654,000 |
|
Investing Cash Flow
|
-317,000 |
| Market Analysis |
Market Cap
|
403,241,771 |
|
Price
|
1.63 |
|
BVPS
|
1.83 |
|
PB
|
0.90 |
|
EPS
|
-0.88 |
|
PS
|
0.30 |
|
FCF
|
-23,971,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/27 |
-0.50 |
3/7 |
-0.28 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ESPR documents filed with the SEC.
ESPR Filings
Clear
